There is growing evidence that adipose tissue plays a key role in the aggravation of COVID-19. One of the theories under investigation is that fat cells (adipocytes) act as a reservoir for SARS-CoV-2 and...
Read More »Exosome-mediated mRNA delivery for SARS-CoV-2 vaccination
In less than a year from its zoonotic entry into the human population, SARS-CoV-2 has infected more than 45 million people, caused 1.2 million deaths, and induced widespread societal disruption. Leading SARS-CoV-2 vaccine candidates immunize with the viral spike protein ...
Read More »COVID-19 and extracellular vesicles – an intriguing interplay
The outbreak of severe acute respiratory syndrome β-coronavirus 2 (SARS-CoV-2) has the potential to become a long-lasting global health crisis. The number of people infected with the novel...
Read More »BrainStorm Announces Groundbreaking Pre-Clinical Study of NurOwn® derived Exosome-Based Treatment for COVID-19 ARDS
BrainStorm Cell Therapeutics Inc, a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today that it has successfully completed its first milestone in developing an innovative exosome-based platform-technology for the treatment severe COVID-19 infection. COVID-19 induced pneumonia ...
Read More »Mesenchymal Stem Cell Derived Exosomes – a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19
The recent pandemic situation transpired due to coronavirus novel strain SARS-CoV-2 has become a global concern. This human coronavirus (HCov-19) has put the world on high alert as the numbers of confirmed cases are continuously increasing. The world is now ...
Read More »Graphene-based strategies in liquid biopsy and in viral diseases diagnosis
Graphene-based materials are intriguing nanomaterials with applications ranging from nanotechnology-related devices to drug delivery systems and biosensing. Multifunctional graphene platforms were proposed for the detection of several...
Read More »On Demand Webinar – COVID-19 experts discuss exosomes and mesenchymal stem cells as experimental treatment for ARDS/COVID-19
In this webinar, learn more about the ongoing research and clinical trials to manage acute respiratory distress syndrome (ARDS) in COVID-19 patients...
Read More »Dangerous rise in sale of Unsubstantiated and unlicensed stem cell and exosome treatments for COVID-19
COVID-19, the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has in a matter of months become a devastating global pandemic and public health emergency...
Read More »A simple blood test to predict severity of COVID-19 in patients
Nanostics is using diagnostic technology to help health professionals intervene more quickly and efficiently with patients who are likely to need hospital care. A University of Alberta spinoff company focused on creating and commercializing non-invasive diagnostic tests is developing a ...
Read More »ISEV and ISCT statement on EVs from MSCs and other cells: considerations for potential therapeutic agents to suppress COVID-19
First described in December 2019, the severe acute respiratory syndrome associated with coronavirus disease 19 (COVID-19) quickly evolved into a pandemic...
Read More »